| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.34 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |